Exploring How HTLV-1 Tax Induces T Cell Leukemia
探索 HTLV-1 税如何诱导 T 细胞白血病
基本信息
- 批准号:6769460
- 负责人:
- 金额:$ 36.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:I kappa B betaamidohydrolasesbiological signal transductioncAMP response element binding proteingenetically modified animalshuman T cell leukemiahuman T cell lymphotropic virus type 1laboratory mousenuclear factor kappa betap53 gene /proteinphosphorylationtranscription factorviral carcinogenesisvirus related neoplasm /cancer
项目摘要
DESCRIPTION (provided by applicant): The type I human T cell leukemia virus (HTLV-I) is a complex type C retrovirus etiologically linked with several diverse human diseases including: (1) the Adult T Cell Leukemia (ATL), an aggressive and usually fatal neoplastic expansion of activated CD4+ T lymphocytes; (2) Tropical Spastic Paraparesis/HTLV-I associated myelopathy (TSP/HAM), a progressive neurodegenerative process involving the spinal cord; and (3) a variety of poorly understood autoimmune or inflammatory diseases that affect different end organs including the eye, salivary glands, joints, and muscle. The molecular basis for HTLV-I transformation of human CD4+ T lymphocytes remains unclear, however, the pX-encoded Tax gene product appears to play a central role. Tax both enhances viral replication and deregulates the expression of various host cell genes by altering the activity of select host transcription factors including NF-kappaB/Rel and CREB/ATF. To define the molecular events associated with full T cell transformation, we will utilize Tax expressing transgenic mice that develop T-cell lymphomas closely resembling ATL. Transgenic animals expressing mutants of Tax that are selectively impaired for NF-kappaB/Rel or CREB/ATF dependent gene expression will be evaluated to define the role played by each of these individual transcription factor pathways in T cell transformation. We will further assess the requirement for continuous Tax or NF-kappaB/Rel expression for maintenance of Tax induced tumors by preparing and studying transgenic animals conditionally expressing Tax or a nondegradable mutant of IkappaBalpha that potently inhibits NF-kappaB/Rel activation by Tax (Specific Aim 1). In a second line of study, we will explore how Tax activates the NF-kappaB/Rel family of transcription factors, following its physical assembly with the IKKgamma subunit of the signalsome complex. The potential recruitment of upstream kinases to the signalsome by Tax and the potential role of Tax oligomerization will be assessed. In related studies, we will test whether the inactivation of the p53 tumor suppressor by Tax involves phosphorylation by the IKK complex. (Specific Aim 2). In a third line of experimentation, we will investigate how Tax induces the sustained, long-term nuclear expression of NF-kappaB, which differs sharply from transient response elicited by physiological stimuli. We will specifically examine whether Tax subverts the generation of negative signals within the IKK complex that normally terminates signalsome action. Additionally, we will explore the potential interplay of Tax with a newly recognized negative pathway of nuclear NF-kappaB regulation involving deacetylation of RelA by histone deacetylase 3. Such deacetylation promotes the rapid nuclear export of RelA and contributes to termination of the NF-kappaB response (Specific Aim 3). Through these combined in vivo and in vitro experiments, we hope to gain key insights into the molecular events underlying HTLV-I Tax mediated leukemogenesis.
描述(由申请人提供):I型人类T细胞白血病病毒(HTLV-I)是一种复杂的C型逆转录病毒,该病毒在病因上与几种多样化的人类疾病联系起来,包括:(1)成人T细胞白血病(ATL),一种积极的且通常是致命的肿瘤性肿瘤性的肿瘤性肿瘤,可激活的CD4+ T lymphopphopphocpytes; (2)热带痉挛性模拟/HTLV-I相关的骨髓病(TSP/HAM),这是一种涉及脊髓的进行性神经退行性过程; (3)各种各样的自身免疫性或炎症性疾病,这些疾病影响了不同的端口器官,包括眼睛,唾液腺,关节和肌肉。人CD4+ T淋巴细胞的HTLV-I转化的分子基础尚不清楚,但是,PX编码的税收基因产物似乎起着核心作用。税收既可以增强病毒复制,又通过改变宿主转录因子的活性(包括NF-kappab/rel和creb/atf)的活性来消除各种宿主细胞基因的表达。为了定义与全T细胞转化相关的分子事件,我们将利用表达转基因小鼠的税收,这些小鼠与ATL非常相似。将评估对NF-kappab/rel或creb/atf依赖基因表达有选择性损害的税收突变体的转基因动物,以定义T细胞转化中这些单个转录因子途径中每个单个转录因子途径的作用。我们将进一步评估通过准备和研究有条件地表达税收或不可分解的ikappabalpha突变体的转基因动物来维持税收诱发肿瘤的持续税或RER表达的要求,从而用不良的ikappabalpha进行了严厉抑制NF-kappab/rel celm activation ta Tax ta Tax ta Tage ta Tax(特定目标1)。在第二次研究中,我们将探讨税收如何激活转录因子的NF-kappab/rel家族,因为它与信号综合体的ikkgmama亚基进行了物理组装。通过税收和税收低聚的潜在作用,上游激酶的潜在募集将评估。在相关研究中,我们将测试通过税收抑制p53肿瘤是否涉及IKK复合物磷酸化的失活。 (特定目标2)。在第三行实验中,我们将研究税收如何诱导NF-kappab的持续长期核表达,这与生理刺激引起的短暂反应截然不同。我们将专门研究税收是否颠覆了通常终止信号动作的IKK综合体内的负面信号的产生。此外,我们将探索涉及组蛋白脱乙酰基酶脱乙酰基的核NF-kappab调节的新认识的负面途径的潜在相互作用。这种脱乙酰基化促进了Rela的快速核出口,并为NF-Kappab响应的终止有助于(特定的AIM AIM 3)。通过这些结合的体内和体外实验,我们希望能够对HTLV-I税收介导的白血病的基础事件获得关键见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Warner C. Greene其他文献
Cytochalasin binding in lymphocytes and polymorphonuclear leukocytes.
淋巴细胞和多形核白细胞中的细胞松弛素结合。
- DOI:
- 发表时间:
1976 - 期刊:
- 影响因子:3.7
- 作者:
C. Parker;Warner C. Greene;Hanna H. MacDonald - 通讯作者:
Hanna H. MacDonald
Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.
白细胞介素2诱导的酪氨酸磷酸化。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:4.8
- 作者:
Gordon B. Mills;Christopher May;Martha McGill;Marion Fung;Michael Baker;Robert Sutherland;Warner C. Greene - 通讯作者:
Warner C. Greene
A role for cytochalasin-sensitive proteins in the regulation of calcium transport in activated human lymphocytes
- DOI:
10.1016/s0006-291x(75)80169-0 - 发表时间:
1975-07-22 - 期刊:
- 影响因子:
- 作者:
Warner C. Greene;Charles W. Parker - 通讯作者:
Charles W. Parker
Analysis of Interleukin-2-dependent Signal Transduction through the Shc/Grb2 Adapter Pathway: INTERLEUKIN-2-DEPENDENT MITOGENESIS DOES NOT REQUIRE Shc PHOSPHORYLATION OR RECEPTOR ASSOCIATION
- DOI:
10.1074/jbc.270.48.28858 - 发表时间:
1995-12-01 - 期刊:
- 影响因子:
- 作者:
Gerald A. Evans;Mark A. Goldsmith;James A. Johnston;Weiduan Xu;Sarah R. Weiler;Rebecca Erwin;O. M. Zack Howard;Robert T. Abraham;J. O'Shea John;Warner C. Greene;William L. Farrar - 通讯作者:
William L. Farrar
CHAPTER 3 – Molecular Biology of HIV: Implications for New Therapies
第 3 章 – HIV 分子生物学:对新疗法的影响
- DOI:
10.1016/b978-1-4160-2882-6.50007-1 - 发表时间:
2007 - 期刊:
- 影响因子:5.2
- 作者:
Warner C. Greene;B. Peterlin;Matthew H. Stremlau - 通讯作者:
Matthew H. Stremlau
Warner C. Greene的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Warner C. Greene', 18)}}的其他基金
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
在脑类器官的单细胞水平上探索 HIV 相关神经认知障碍 (HAND) 和 HIV 潜伏期
- 批准号:
10237149 - 财政年份:2019
- 资助金额:
$ 36.52万 - 项目类别:
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
在脑类器官的单细胞水平上探索 HIV 相关神经认知障碍 (HAND) 和 HIV 潜伏期
- 批准号:
10006808 - 财政年份:2019
- 资助金额:
$ 36.52万 - 项目类别:
Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse
评估使用滥用药物的艾滋病毒感染者慢性炎症的根本原因
- 批准号:
9761514 - 财政年份:2017
- 资助金额:
$ 36.52万 - 项目类别:
Project 2: Delineating virus and host cell-derived biomarkers predicting time to HIV rebound after treatment interruption
项目 2:描绘病毒和宿主细胞衍生的生物标志物,预测治疗中断后 HIV 反弹的时间
- 批准号:
10223996 - 财政年份:2017
- 资助金额:
$ 36.52万 - 项目类别:
Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption
利用宿主-HIV 界面识别生物标志物,预测治疗中断后病毒反弹的时间
- 批准号:
9754763 - 财政年份:2017
- 资助金额:
$ 36.52万 - 项目类别:
HIV without AIDS: A Radically Different Approach to Help the Developing World
没有艾滋病的艾滋病毒:帮助发展中国家的完全不同的方法
- 批准号:
9503875 - 财政年份:2013
- 资助金额:
$ 36.52万 - 项目类别:
HIV without AIDS: A Radically Different Approach to Help the Developing World
没有艾滋病的艾滋病毒:帮助发展中国家的完全不同的方法
- 批准号:
8606334 - 财政年份:2013
- 资助金额:
$ 36.52万 - 项目类别:
HIV without AIDS: A Radically Different Approach to Help the Developing World
没有艾滋病的艾滋病毒:帮助发展中国家的完全不同的方法
- 批准号:
8856536 - 财政年份:2013
- 资助金额:
$ 36.52万 - 项目类别:
HIV-Induced CD4 T-Cell Depletion: An Innate Host Defense Gone Awry?
HIV 诱导的 CD4 T 细胞耗竭:先天宿主防御出了问题?
- 批准号:
8411054 - 财政年份:2012
- 资助金额:
$ 36.52万 - 项目类别:
相似国自然基金
氨基甲酸乙酯水解酶酸性环境中稳定性降低的分子机制研究
- 批准号:32302246
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
水解酶和N-乙酰氨基葡萄糖转运蛋白在结瘤和丛枝菌根共生中应答调节的作用
- 批准号:
- 批准年份:2021
- 资助金额:300 万元
- 项目类别:
地衣芽胞杆菌Tat信号肽介导PGase分泌表达机制探究
- 批准号:31601407
- 批准年份:2016
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
除草剂利谷隆的微生物代谢机制与矿化关键菌群的结构与功能
- 批准号:31670111
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
内源性大麻素失活系统介导的EMA神经保护作用及其机制
- 批准号:81171245
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
TP-R: a novel mediator of obesity-linked insulin resistance in humans
TP-R:人类肥胖相关胰岛素抵抗的新型介质
- 批准号:
10709488 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
TP-R: a novel mediator of obesity-linked insulin resistance in humans
TP-R:人类肥胖相关胰岛素抵抗的新型介质
- 批准号:
10426085 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
Sphingolipid-mediated dysregulation of glucose and energy homeostasis by POMC neurons
POMC 神经元鞘脂介导的葡萄糖和能量稳态失调
- 批准号:
9050560 - 财政年份:2015
- 资助金额:
$ 36.52万 - 项目类别:
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 36.52万 - 项目类别: